SBC Medical Group (SBC) Stock Price, News & Analysis

Company Overview

SBC Medical Group (NASDAQ: SBC) is a Japan-based medical services and management company focused primarily on the aesthetic medicine sector. Through its affiliated medical corporations and clinic network, the company supports the operation of facilities offering cosmetic surgery, cosmetic dermatology and related elective treatments.

The company provides a range of management and operational services to affiliated clinics, including branding and marketing, staff recruitment and training, purchasing, information technology, administrative support and business consulting. Its platform is designed to help medical providers standardize operations, expand their services and improve the patient experience while allowing physicians to remain responsible for clinical care.

SBC Medical Group originated in Japan and is associated with the Shonan Beauty Clinic brand. In addition to its Japanese operations, the company has pursued international expansion, including activities in the United States and other overseas markets. Its services and affiliated facilities may also encompass areas adjacent to aesthetic medicine, such as dental care, hair restoration and regenerative medicine, depending on the location and medical provider.

Key Stats

• Today's Range: $4.66 to $4.84
• 50-Day Range: $2.93 to $5.14
• 52-Week Range: $2.78 to $5.29
• Volume: 133,935 shs
• Average Volume: 110,308 shs
• Market Capitalization: $494.49 million
• P/E Ratio: 10.22
• Dividend Yield: N/A
• Price Target: $8.50
• Consensus Rating: Moderate Buy

SBC Medical Group Stock Analysis - MarketRank™

SBC Medical Group scored higher than 84% of companies evaluated by MarketBeat, and ranked 69th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

SBC Medical Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

SBC Medical Group has a consensus price target of $8.50, representing about 80.9% upside from its current price of $4.70.

Amount of Analyst Coverage

SBC Medical Group has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 18.18%

Earnings Growth

Earnings for SBC Medical Group are expected to grow by 18.18% in the coming year, from $0.44 to $0.52 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of SBC Medical Group is 9.97, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.91.

Price to Earnings Ratio vs. Sector

The P/E ratio of SBC Medical Group is 9.97, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.95.

Price to Book Value per Share Ratio

SBC Medical Group has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.70% of the float of SBC Medical Group has been sold short.

Short Interest Ratio / Days to Cover

SBC Medical Group has a short interest ratio ("days to cover") of 3.43, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SBC Medical Group has recently increased by 3.21%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SBC Medical Group does not currently pay a dividend.

Dividend Growth

SBC Medical Group does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.21

News Sentiment

SBC Medical Group has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for SBC Medical Group this week, compared to 3 articles on an average week.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SBC Medical Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

81.70% of the stock of SBC Medical Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

60.82% of the stock of SBC Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 9/24/2026
• Lytham Partners Fall 2026 Investor Conference: 9/29/2026
• Next Earnings (Estimated): 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:SBC
• Previous Symbol: NASDAQ:SBC
• CIK: 1930313
• Web: sbc-holdings.com
• Phone: (949) 593-0250
• Fax: N/A
• Employees: 863
• Year Founded: N/A

Price Target and Rating

• Average Price Target for SBC Medical Group: $8.50
• High Price Target: $9.00
• Low Price Target: $8.00
• Potential Upside/Downside: +77.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.47
• Trailing P/E Ratio: 10.13
• Forward P/E Ratio: 10.86
• P/E Growth: N/A
• Net Income: $50.99 million
• Net Margins: 27.99%
• Pretax Margin: 43.09%
• Return on Equity: 18.47%
• Return on Assets: 13.10%

Debt

• Debt-to-Equity Ratio: 0.09
• Current Ratio: 3.31
• Quick Ratio: 3.27

Sales & Book Value

• Annual Sales: $175.17 million
• Price / Sales: 2.81
• Cash Flow: $0.50 per share
• Price / Cash Flow: 9.63
• Book Value: $2.57 per share
• Price / Book: 1.86

Miscellaneous

• Outstanding Shares: 102,847,000
• Free Float: 18,821,000
• Market Cap: $491.61 million
• Optionable: N/A
• Beta: 0.63